MIT Technology Review Subscribe

A smart pill to track IBD

The ingestible device combines engineered bacteria with low-power electronics to monitor gut inflammation in real time.

Roughly 7 million people around the world cope with inflammatory bowel diseases like colitis or Crohn’s, and current diagnostic techniques make monitoring and treating them a challenge. But a “smart pill” developed by researchers from MIT, Boston University, and elsewhere could be a game changer. 

The pill, which is the size of a blueberry and safe to swallow, can automatically detect key indicators of IBD and makes it possible to track them in real time. Living bacteria enclosed in it have been engineered to produce light when they encounter certain biological molecules such as nitric oxide and byproducts of gut sulfur metabolism, all of which mediate or are linked to intestinal inflammation. These are often short-lived, so they are hard to detect with current techniques such as colonoscopy, which are also much more invasive.

Advertisement

Once the bacteria light up, electronics within the pill convert that light into a wireless signal that can be transmitted to a smartphone or computer as it travels through the gut. The researchers showed that the bacteria could not only detect nitric oxide but distinguish between different concentrations of it, a key to catching an inflammatory flare-up before symptoms begin. 

This story is only available to subscribers.

Don’t settle for half the story.
Get paywall-free access to technology news for the here and now.

Subscribe now Already a subscriber? Sign in
You’ve read all your free stories.

MIT Technology Review provides an intelligent and independent filter for the flood of information about technology.

Subscribe now Already a subscriber? Sign in

The pill, which has been tested in pigs, could also be tweaked to detect other biomarkers and help scientists understand the gut microbiome or develop other health monitoring techniques.

Currently, the gut is like a black box, says Maria Eugenia Inda, an MIT postdoc who reported the results in August together with MIT research scientist Miguel Jimenez; associate professors Timothy Lu ’03, MEng ’03, PhD ’08, and Giovanni Traverso are among the senior authors. “We still don’t fully understand it because it’s difficult to access and study. We lack the tools to explore it,” she says. “Knowing more about the gut chemical environment could help us prevent disease by identifying factors that cause inflammation before the inflammation takes over.” 

This is your last free story.
Sign in Subscribe now

Your daily newsletter about what’s up in emerging technology from MIT Technology Review.

Please, enter a valid email.
Privacy Policy
Submitting...
There was an error submitting the request.
Thanks for signing up!

Our most popular stories

Advertisement